News
With measles outbreaks, avian influenza and syphilis and HIV on the rise, Canada needs to strengthen its disease surveillance ...
New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new ...
Continued exposure to fine particulate matter is linked to higher levels of diffuse myocardial fibrosis, according to a study ...
While Jake MacDonald now has a clean bill of health, he's launched a sun safe clothing business and is working to raise ...
Health-care experts and advocates say Gilead's HIV prevention shot could be a "wonder drug," but there are concerns about accessiblity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results